Latest Operating Expenses News

Beam Communications reported a modest adjusted cash outflow in Q4 FY25 despite a 36% revenue drop due to delivery delays and sales transitions, while cost-cutting efforts continue to bolster its financial resilience.

Pureprofile has reported record FY25 results, with revenue climbing 19% and EBITDA up 18%, driven by strong international growth and innovative AI platform launches.

Global Health Limited reported a robust June quarter with a 65% rise in annual sales and a strategic pivot towards AI-driven efficiencies, aiming for profitability by mid-2026.

Multistack International has announced the discontinuation of its current business operations following a significant asset sale that settled a $3.55 million loan, signaling a major strategic shift for the company.

Oneview Healthcare reported a €4 million cash outflow in Q2 2025, driven by restructuring and lower R&D credits, while securing new US hospital contracts and expanding AI-powered care solutions.

icetana Limited reports its strongest quarterly annual recurring revenue growth in over four years, boosted by a landmark $3.6 million strategic partnership with SoftBank Robotics Group and expanding global deployments.

Highfield Resources has entered a significant non-binding agreement with China’s Qinghai Salt Lake Industry for a US$300 million equity injection, aiming to fast-track its Muga potash mine development and expand its global footprint.

Lake Resources reports a significant 40% reduction in quarterly cash expenditures alongside a 10% increase in lithium resources at its flagship Kachi project, while advancing key development milestones and exploring strategic options.

Brookside Energy reports robust early production from its ninth horizontal well in the SWISH Play, delivering solid cash flow and promising project economics.

Firebrick Pharma has published positive Phase 3 clinical trial results for its Nasodine nasal spray, showing efficacy against the common cold, while reporting encouraging sales growth in Singapore and the US. However, a recent capital raise fell well short of targets, casting uncertainty over its expansion plans.

Bod Science reports a solid net cash inflow of $858,000 in Q4 FY2025, driven by R&D incentives and Biortica funding, while awaiting shareholder approval to complete a key acquisition.

MOVE Logistics Group has achieved its FY25 financial targets, showcasing significant improvements in earnings and operational efficiency despite a tough economic backdrop in New Zealand.